Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · April 20, 2023

Efficacy and Safety of Baricitinib in Combination With Topical Corticosteroids in Pediatric Patients With Moderate to Severe Atopic Dermatitis

The British Journal of Dermatology


Additional Info

Disclosure statements are available on the authors' profiles:

The British Journal of Dermatology
Efficacy and safety of baricitinib in combination with topical corticosteroids in pediatric patients with moderate-to-severe atopic dermatitis with inadequate response to topical corticosteroids: results from a phase 3, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS)
Br J Dermatol 2023 Mar 31;[EPub Ahead of Print], A Torrelo, B Rewerska, M Galimberti, A Paller, CY Yang, A Prakash, D Zhu, MAG Pontes Filho, WS Wu, L Eichenfield

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading